Skip to main content
. 2017 Sep 6;8(16):3122–3129. doi: 10.7150/jca.22046

Figure 1.

Figure 1

Figure 1

A comparison of the distribution of BRMS1 expression status between fascin- and fascin+ breast cancers. (a) Distribution of nuclear BRMS1 expression, (b) distribution of cytoplasmic BRMS1expression, (c) distribution of low and high BRMS1 H scores, (d) difference in mean BRMS1 H scores.